Salute e Benessere

Genotyping Assay Market Surges to USD 37.1 Billion by 2029: Thermo Fisher and…

Browse in-depth TOC on "Genotyping Assay Market" Browse in-depth TOC on "Genotyping Assay Market" 444 - Tables 59 - Figures 388 - Pages TheMay 2024edition of the genotyping assay market report introduces significant enhancements and updates to provide a comprehensive view of the market: These enhancements in theMay 2024edition aim to deliver deeper insights and a more comprehensive understanding of the genotyping assay market, aiding stakeholders in strategic...

Flame Resistant and Retardant Fabric Market is Anticipated to reach US$ 13.39…

Flame-resistant and retardant fabrics are engineered to self-extinguish or resist the spread of flames by minimizing the risk of devastating fires and potential loss of life. Demand growth for these fabrics is being led by stringent fire safety regulations and heightened awareness of workplace hazards, especially in critical sectors such as oil & gas exploration, mining, and manufacturing. Flame-resistant and retardant fabrics are engineered to self-extinguish or resist the spread of flames…

Home Medical Equipment Market to be Worth $62.89 Billion by 2030 - Exclusive…

Home medical equipment is used to fulfill patients' healthcare needs at home. It is mostly used when a patient or individual requires prolonged care or stays in healthcare facilities. Home medical equipment includes therapeutic, mobility, assistive, and patient support equipment used by individuals or patients to control numerous conditions, such as respiratory diseases, mobility disorders, and cancer. Home medical equipment is used to fulfill patients' healthcare needs at home. It is mostly...

Philips completes cancellation of 4.4 million shares

Amsterdam, the Netherlands –Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021.Philips' current issued share capital amounts to EUR 187,987,876.80 representing 939,939,384 common shares.More information is available here . For further...

BULLETIN FROM THE ANNUAL GENERAL MEETING ON 19 JUNE 2024 IN IMMUNOVIA AB (PUBL)

The annual general meeting resolved to adopt the profit and loss account and balance sheet and the consolidated profit and loss statement and consolidated balance sheet. The annual general meeting also resolved to allocate the company's result in accordance with the board's proposal, which means that no dividend will be paid, and that available funds of SEK 60,668,202 will be carried forward. The annual general meeting resolved to adopt the profit and loss account and balance sheet and the...

Daewoong Presents Enavogliflozin's Phase 3 Pooled Analysis Results at 84th ADA…

The study shows Enavogliflozin's superior blood glucose-lowering effects compared to dapagliflozin, with a significant reduction in glycated hemoglobin (HbA1c) levels. Over 24 weeks, Enavogliflozin reduced HbA1c by 0.94%, compared to 0.77% with dapagliflozin. Additional benefits include reduced fasting plasma glucose levels, increased urinary glucose excretion, and improved insulin resistance. The study shows Enavogliflozin's superior blood glucose-lowering effects compared to dapagliflozin,...

Smartee Presents Two Decades of Progress at the 99th EOS Congress in Athens

Smartee's booth at the EOS Congress drew significant attention from orthodontists eager to explore the company's two decades of achievement. Highlights included: Smartee's booth at the EOS Congress drew significant attention from orthodontists eager to explore the company's two decades of achievement. Highlights included: As part of its participation at EOS, Smartee hosted an educational workshop led by Dr. Tao Guo, which provided attendees with valuable insights into Smartee GS Mandibular...

Gareth Williams appointed CEO of Bionical Health

Bionical Health is the rebranded Health Outcomes (Clinical) division of Bionical Solutions. In May, Bionical Solutions decided to demerge two of its business divisions, Multi-Channel Engagement (Commercial) and Health Outcomes (Clinical), into separate legal and operating entities within the parent company to afford each business greater autonomy to focus on its specific growth requirements and better meet the needs of clients. The demerger will complete on 1 August 2024. Bionical Health is…

Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New…

Major pharmaceutical companies are eager to partner with or acquire ADC developers to enhance their oncology pipelines. ADCs combine a cytotoxic payload, a monoclonal antibody (mAb), and a chemical linker, offering greater target specificity and a wider therapeutic index than traditional therapies, delivering toxic agents directly to cancer cells while sparing healthy tissues. Major pharmaceutical companies are eager to partner with or acquire ADC developers to enhance their oncology…

Implantica announces further expansion of RefluxStop™ access in the UK NHS…

He says: "The patient is doing well following surgery; she recovered quickly and was eating normally within days. Her severe symptoms, including vomiting, chest pain, sore throat, reflux, and epigastric pain and discomfort, have all been resolved without the need for ongoing medication." He says: "The patient is doing well following surgery; she recovered quickly and was eating normally within days. Her severe symptoms, including vomiting, chest pain, sore throat, reflux, and…

European Commission grants Sobi® Marketing Authorisation for ALTUVOCT™ for…

"Despite advancements, haemophilia still limits the possibilities of patients' lives and this means there is still a need for treatments that offer elevated protection. ALTUVOCT's high-sustained factor VIII activity and once-weekly dosing schedule have the potential to significantly improve quality of life for people with haemophilia A. The trials demonstrated substantial improvements in the prevention and treatment of bleeds along with significant improvements in physical health, pain, and…

DNA Health & Wellness, the MENA Regions' Largest Health Optimisation and…

"We are excited to bring our innovative approach to health and wellness toAbu Dhabi. Our success inDubaihas demonstrated that there is a strong demand for personalised and preventative healthcare; our expansion reflects our commitment and mission to making advanced health solutions more accessible to a wider community."DrNasr Al Jafari, Co-Founder & Chief Medical Officer of DNA Health & Wellness Group. Located inCentral Abu Dhabi, the expansion marks a...

ZA Tech Rebrands as Peak3, Raises US$35M Series A led by EQT

Besides the successful fundraising, Peak3 has recently achieved key milestones underpinning the rebranding. These transformative achievements include launching its first multi-country, multi-tenant core modernisation in Europe, rolling out an integrated customer data and big data platform for scaling analytics and AI capabilities, and establishing its first technology centre in Europe. The rebranding coincides with another major milestone: Issuing over a billion insurance policies on Peak3's…

Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL…

CLTI and CLI are debilitating conditions that affect the blood vessels in the legs and feet. Those afflicted with this disease often suffer from severe pain, numbness, and open non-healing wounds. Without intervention, these conditions can lead to amputation, loss of mobility, and death. Micro Medical Solutions is committed to providing a potential solution for this medically complex and underserved patient population. CLTI and CLI are debilitating conditions that affect the blood vessels in...

Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key…

Key Takeaways from the Obesity Market Report Key Takeaways from the Obesity Market Report Discover which therapies are expected to grab major obesity market share @Obesity Market Report Obesity Overview Obesity is acknowledged as a chronic condition or noncommunicable ailment, characterized by a complex, multifaceted set of factors. It predominantly involves excessive body fat, along with being overweight, which can have metabolic implications beyond just physical size...

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; June 18, 2024 –Genmab A/S(Nasdaq: GMAB) will increase its share capital by 6,986 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1:424 shares at DKK 1,025.00, 2,305 shares at DKK 1,032.00, 1,058 shares at DKK 1,161.00, 562 shares at...

EssilorLuxottica and Diesel announce a ten-year licensing agreement

ESSILORLUXOTTICA AND DIESEL ANNOUNCE A TEN-YEAR LICENSING AGREEMENT Charenton-le-Pont, France and Milan, Italy (18 June 2024)– EssilorLuxottica and Diesel announced today that they have signed an exclusive license agreement for the design, manufacture, and worldwide distribution of Diesel eyewear. The agreement will be effective immediately until December 31, 2029, with an automatic renewal option of an additional five years. The first collection under the agreement will be...

Actions to strengthen presence in North Africa : Congress & Surgeons trainings

Press release Ecully, June 18, 2024 – 6 p.m. Presentation of the KAPHORN system to 200 surgeons at the SOTCOT Congress in Hammamet The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, was represented at the 39th edition of theTunisian Orthopedic Society (SOTCOT)Congress, held from June 6 to 8 in Hammamet, Tunisia. Dr. Radwan Hilmi (Head of Orthopedics and Traumatology Department at Hôpital Nord Ouest,...

IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2024

AggregatedpresentationbydayandbymarketPurchases of own shares from June 10th to 14th 2024 Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1110/06/2024FR00102591505 000122,0351XPARIPSEN549300M6SGDPB4Z94P11...

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest…

Findings Show Trends for Reduced Toxicities and Better Outcomes for Subjects Receiving ONIVYDE/5-FU Combination and Targeted anti-IL-1alpha Therapy /Phase 2 randomized, double-blind, placebo-controlled multi-center study for advanced pancreatic cancer. Known as 1-BETTER, the study examined Natrunix (anti-interleukin-1alpha) antibody in combination with an established chemotherapy regimen (ONIVYDE (ON) + 5-Fluorouracil (5FU) + Leucovorin (LV), a regimen that is already widely used for…

Oblique Therapeutics and the KTH Royal Institute of Technology (KTH) have…

About Oblique Therapeutics About Oblique Therapeutics Oblique Therapeutics is a biotechnology company that focuses on developing new therapeutic methods for treating severe illnesses, especially in the area of pain management and also for other conditions. The company uses pioneering technology and innovative research methods to discover and develop new drug candidates. About the KTH Royal Institute of Technology (KTH) KTH is the biggest technical university inSwedenand is one...

Healthcare BPO Market Anticipates USD 626.6 Billion by 2029 with 9.7% CAGR |…

Browse in-depth TOC on "Healthcare BPO Market" Browse in-depth TOC on "Healthcare BPO Market" 360 - Tables 60 - Figures350 - Pages Elevating Healthcare Efficiency: Driving Cost Reduction Through Strategic BPO Excellence The imperative to curb rising healthcare costs is a pivotal driver propelling growth within the healthcare BPO market. As healthcare expenditures surge, organizations face mounting pressure to optimize financial efficiencies. Outsourcing non-core...

Orthopedic Braces & Supports Market to Be Worth $4.64 Billion by 2031 -…

The growth of the orthopedic braces & supports market is driven by the increasing cases of bone fracture, the growing incidence of musculoskeletal disorders, and the growing availability & affordability of orthopedic support products. However, individuals' tendency to ignore smaller injuries and low awareness regarding bracing-mediated orthopedic treatments restrain the growth of this market. The growth of the orthopedic braces & supports market is driven by the increasing cases of…

Ceruvia Founder and CEO, Carey Turnbull, Featured in New Book "Psychedelic…

"Psychedelic Outlaws" chronicles the extraordinary journey of a group of individuals debilitated by cluster headaches, often referred to as 'suicide headaches' due to their extreme pain. Among these trailblazers is Bob Wold and the organization Clusterbusters®, dedicated advocates for those suffering from this debilitating condition. "Psychedelic Outlaws" chronicles the extraordinary journey of a group of individuals debilitated by cluster headaches, often referred to as…

Altri Comunicati